News Chart Daxor Corporation

Equities

DXR

US2394671034

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-06-13 pm EDT			5-day change	1st Jan Change
9 ^USD	+1.69%		-0.55%	-6.25%

Jun. 05	Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer	CI
Apr. 16	Daxor Corporation Announces Two New Studies Validating the Clinical Benefits of Daxor?s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion	CI

825108ab45a80682daf200.lbvyMjndsVf3YDJ_BCUKw_cmdkbxqBcWtwzeZMBp1Ds.18OhXViVwQ2VNlsnKRxHoLV5Qyio-FlHwnysFZRY4FnB9LpqeLXGLZUIAg~f3dea263ca1b60e7492f049d9506b098